Business Blockbuster - Helpng business to be more visible on Google
The Times Australia

TempraMed Signs Exclusive Distribution Agreement with DayMed Qatar, Expanding Gulf Region Commercial Footprint

Approximately US$500,000 in potential purchases over the initial three-year term, based on VIVI Cap minimum volumes; agreement targets Qatar's high-prevalence diabetes market through hospital and pharmacy channels

Highlights

  • Exclusive distribution arrangement in Qatar with an initial 36-month term, intended to support local registration, marketing, sale and distribution of TempraMed products
  • Minimum unit purchase commitment with first purchase order paid in full before shipment, represents approximately $US 500,000 potential sales, subject to regulatory clearance, continued compliance with the Distribution Agreement and fulfillment of applicable purchase commitments
  • Qatar had an estimated 409,300 adults with diabetes in 2024 and 24.6% age-standardized adult diabetes prevalence, according to the International Diabetes Federation (IDF)
  • DayMed brings nearly five years of local market experience and reports commercial relationships with hospitals and major pharmacy chains, supporting a focused patient-access strategy
Toronto, Canada - Newsfile Corp.

- November 16, 2026 - TempraMed Technologies Ltd. (CSE: VIVI) (FSE: 9DY) (OTCQB: TMPTF) ("TempraMed" or the "Company"), a medical-technology innovator transforming how temperature-sensitive medications are stored and managed, is pleased to announce that it has entered into a definitive exclusive distribution agreement dated November 7, 2026 (the "Distribution Agreement") with DayMed Trading ("DayMed" or the "Distributor") for commercialization of TempraMed's medication temperature-protection products in the State of Qatar.

Under the Distribution Agreement, with a three-year commercial opportunity of approximately US$500,000, DAYMED will serve as TempraMed's exclusive distributor in Qatar for the Company's products. The initial focus is VIVI Cap™, TempraMed's reusable, passive temperature-protection solution for insulin pens with further expansion to include VIVI Cap Smart™ and VIVI Med™ as potential products within the distribution framework.

"Our agreement with DayMed is another meaningful step in building a scalable international distribution network through partners who understand their local healthcare systems," said Ron Nagar, Chief Executive Officer and Founder of TempraMed. "Qatar presents a compelling combination of high diabetes prevalence, increasing attention to metabolic health and a climate in which patients must take particular care to protect temperature-sensitive medications during day-to-day life."

"The approximately half-million-dollar potential under the initial agreement is an important commercial opportunity, but the strategic value goes beyond the contractual purchase volumes," added Nagar. "DayMed's relationships with hospitals and pharmacy chains can help bring VIVI Cap closer to patients at the point of prescription and dispensing. We believe this model can support long-term growth as TempraMed expands through healthcare and pharmacy channels across the Gulf region."

Qatar Market Opportunity for Medication Temperature Protection

According to the IDF Diabetes Atlas, approximately 409,300 adults aged 20–79 were living with diabetes in Qatar in 2024, with an age-standardized diabetes prevalence of 24.6%—among the highest rates globally. These estimates reflect the substantial population potentially requiring long-term diabetes care, including patients prescribed injectable insulin therapies. [1, 2]

Obesity and related metabolic conditions reinforce the relevance of injectable-therapy support. A peer-reviewed analysis of Qatar's 2023 STEPwise Survey, published in BMJ Open in October 2026, reported obesity among 37.8% of surveyed adults aged 18–69 and overweight among another 36.4%. While these figures do not measure GLP-1 prescriptions or TempraMed's directly addressable customer base, they provide independent context for the growing importance of metabolic health and treatment-support solutions. [3]

Qatar's Government Communications Office describes the country's summers as hot and humid, with temperatures ranging from 25°C to 46°C. Such conditions make appropriate handling of temperature-sensitive medicines particularly important during commuting, travel, outdoor activities and transport from pharmacy to home. TempraMed's solutions are designed to provide practical thermal protection during permitted in-use conditions, while users must continue to follow each medication manufacturer's labeled storage instructions. [4]

About DAYMED Qatar

DayMed Trading is a Qatar-based healthcare distributor with nearly five years of local market experience. According to information provided by DayMed, its portfolio includes medical devices, pharmaceuticals and children's multivitamins, and the company works with hospitals and major pharmacy chains across Qatar. Through its partnership with TempraMed, DayMed intends to introduce VIVI Cap to patients who use insulin, combining local healthcare-channel experience with TempraMed's patented medication temperature-protection technology.

About TempraMed Technologies Ltd.

TempraMed Technologies Ltd. is a global medical-device company with a portfolio of innovative, temperature-controlled medication-storage solutions. Founded with the mission to safeguard the effectiveness of life-saving medications, TempraMed develops patented, FDA-registered thermal-insulation devices that operate continuously without batteries or external power. Its commercial product portfolio includes VIVI Cap™, VIVI Cap Smart™, VIVI Epi™, and VIVI Med™. TempraMed enables patients and healthcare providers to confidently manage temperature-sensitive medications anywhere, anytime.

Investors interested in learning more about TempraMed are encouraged to contact the Company at:
ir@tempramed.com
www.tempramed.com

Contact:
Julia Becker
Director & Capital Markets
T: +1 (604) 785-0850
E: julia@tempramed.com

Media:
Brenda Zeitlin
Vice President, Marketing
E: brenda@tempramed.com

Independent Market Sources
1. International Diabetes Federation (IDF), Qatar country profile, Diabetes in Qatar (2024): 409,300 adults with diabetes. https://idf.org/our-network/regions-and-members/middle-east-and-north-africa/members/qatar/
2. IDF Diabetes Atlas, Qatar country report: 2024 age-standardized diabetes prevalence of 24.6% among adults aged 20–79. https://diabetesatlas.org/data-by-location/country/qatar/
3. Al-Thani MH et al., "Prevalence, risk factors and comorbidities of overweight and obesity among adults in Qatar: a cross-sectional analysis of the 2023 Stepwise Survey," BMJ Open, October 2026. https://bmjopen.bmj.com/content/16/10/e110307
4. State of Qatar, Government Communications Office, "Facts about Qatar," climate information. https://www.gco.gov.qa/en/state-of-qatar/facts-about-qatar/

Cautionary Statements
THE CANADIAN SECURITIES EXCHANGE HAS NOT REVIEWED AND DOES NOT ACCEPT RESPONSIBILITY FOR THE ACCURACY OR ADEQUACY OF THIS RELEASE, NOR HAS OR DOES THE CSE'S REGULATION SERVICES PROVIDER.

This press release contains "forward-looking information" and "forward-looking statements" within the meaning of applicable Canadian securities legislation. Forward-looking statements may be identified by words such as "anticipate," "believe," "expect," "intend," "may," "plan," "potential," "should," "strategy," "will" and similar expressions, or statements concerning events or conditions that may occur in the future.

Forward-looking statements in this press release include, without limitation, statements regarding the anticipated commercialization of TempraMed products in Qatar; the Distributor's ability to obtain required regulatory clearance; the timing and completion of product registration, importation and commercial launch activities; the fulfillment of purchase commitments; the potential aggregate value of the Distribution Agreement; consumer adoption of the products; market demand for temperature-protection solutions for insulin, GLP-1 therapies, biologics and other injectable medications; the Distributor's capacity to develop hospital and pharmacy channels; anticipated minimum order volumes; potential aggregate purchases and the actual product mix; future market demand; and the Company's ability to expand across Qatar and the Gulf region. The approximately US$500,000 value is an illustration based on the specified minimum annual quantities and applicable VIVI Cap pricing tiers, not a guarantee of realized revenue.

Forward-looking statements are based on the opinions, expectations and assumptions of management as of the date of this press release, including assumptions regarding receipt of required regulatory approvals, compliance by the Distributor with the Distribution Agreement, market acceptance of TempraMed products, the Distributor's ability to commercialize the products in Qatar, and continued demand for medication temperature-protection solutions.

Forward-looking statements are subject to known and unknown risks, uncertainties and other factors that may cause actual results to differ materially from those expressed or implied, including regulatory approval and import requirements, the possibility that purchase commitments may not be fulfilled, changes in market demand, competitive developments, distributor performance, geopolitical risks, general economic conditions, supply-chain limitations, and other risks described in the Company's public filings available on SEDAR+.

Except as required by applicable securities laws, the Company undertakes no obligation to update or revise publicly any forward-looking statements.

The issuer is solely responsible for the content of this announcement.

Read more: TempraMed Signs Exclusive Distribution Agreement with DayMed Qatar, Expanding Gulf Region Commercial...

More Articles …

  1. 11 Boutique Xinjiang Wineries to Debut in Singapore
  2. News Lounge Comes to Türkiye, Fostering Dialogue Across Borders
  3. TORRAS Launches Two New iPhone Duo Cases from Its Popular Ostand Series, Addressing Foldable Phone Users’ Concerns About Difficult Stand Positioning and Scratches
  4. Sun World Ba Den Mountain marks Vietnam Culture Day, welcoming Cambodian visitors over Bon Om Touk
  5. EBANX and Eneba strengthen partnership in Latin America with 138% YoY growth in payment volume
  6. L’OCCITANE Celebrates 50 Years Of Provençal Craftsmanship With Holiday 2026 Collection
  7. Yicura BioMed Advances Dual Capital and Industrial Strategy: Completes First Closing of Series B Financing Led by Gobi Partners
  8. LOCUS-T and My Starfish Foundation Launch Illustrated Cancer Book to Make Cancer Information More Accessible
  9. From Message to Mandate: PRISM Summit 2026 Calls on Communicators to Claim Their Seat at the Governance Table
  10. Former Tencent Cloud AI Executive Eric Muqing Li Appointed Co-CEO of Education AI Company Qimingdaren
  11. Chongqing: Forging New Connections Across Eurasia — Industry Matchmaking Conference of Chongqing Visit by Eurasian Enterprises Held
  12. Bora Group 3Q26: Revenue and Net Income Expansion Continues U.S. Manufacturing and Biologics Footprint Complete; Margin Expansion to Follow as Utilization Improves
  13. Vesalius Longevity Labs Appoints Harvey Spevak as Chairman to Accelerate Global Growth and Brand Development
  14. CALL-E Lets AI Agents in ChatGPT, Muse and OpenClaw Make Real Phone Calls on Their Users' Behalf
  15. ATI Secures Manila South Harbour Concession Renewal To 2063
  16. Somerset Clarke Quay Singapore To Open On 15 December 2026, As A New Global Flagship For The Somerset Brand
  17. Ride, eat and save: foodpanda teams up with HelloRide to bring everyday perks to Singaporeans
  18. SEVENTEEN’s JEONGHAN X JOSHUA Partner With ENYA MUSIC as Global Brand Ambassadors for DREAMSCAPE Collection
  19. Hongkong Land Unveils LANDMARK Orchard as New Name for Wheelock Place
  20. HEIDELBERG sees sequential improvement in business performance in a challenging geopolitical environment
  21. Hong Kong Disneyland Welcomes International Tennis Stars from Hong Kong Tennis Open 2026
  22. HKBU-led Jockey Club Multiple Pathways Initiative – CLAP-TECH Pathway Advances VPET in Mainstream Education with New Additions to Its Senior Secondary Programme
  23. Ping An Digital Bank Deepens Purchase Order Financing Scenarios, Expands into Service Trade Financing Market
  24. MBI Selangor’s Karnival Ban Canal 2026 Draws Over 38,000 Visitors And Generates Nearly RM125,000 For Local Vendors
  25. Jotun Marks 100 Years with Global Colour Collection 2027 and the Next Generation of Majestic True Beauty
  26. Final Call: Secure a Fully-Funded PhD at World #18 CUHK Before 1 December
  27. When Pets Are Part of the Family, Choosing Where to Stay Means Caring for Every Member
  28. ONYX Hospitality Group Unveils Plans for Amari Samui Resort and Villas, Elevating Its Premium Resort Offering on Koh Samui
  29. Somerset Diamond Bay Garden Phnom Penh Opens Its Doors, Bringing A New Living Experience To Koh Pich
  30. LANDMARK Presents ‘Destination CENTRAL’: A District-Wide Celebration Inviting Global Travellers to Explore the Dynamism, Luxury, and Soul of Central
  31. Vesalius Longevity Labs Commences Trading Today on the Canadian Securities Exchange Under the Symbol "VLAB"
  32. Quantropi Enters Vietnam Market Through Strategic Partnership with VNet to Advance Post-Quantum Readiness
  33. SCG Outlines Vision to Strengthen ASEAN Industrial Competitiveness, Accelerating Business Transformation Through Innovation, Technology and Strategic Collaboration at Fortune Southeast Asia 500 Summit 2026
  34. Angel Health Medical Announces Medical Weight Management Service Arrangements
  35. One Industry, One Fair: MIFF 2027 Unites Malaysia’s Furniture Industry With MATRADE, MFA, AND MFC
  36. Panasonic Singapore Brings Back Highly Anticipated Japan Tour Lucky Draw
  37. Careers Are Changing: ISCA Launches FlexConnect to Offer Accountants New Ways to Work
  38. As AI Reshapes Accounting Jobs, ISCA Partners With All Five Polytechnics and ITE to Prepare Future Talent
  39. P-CRAFT: Connecting Global Partners to Transform Climate-Resilient Agrifood Value Chains
  40. Bangkok Welcomes Global Creative Communities for THE WORLD ENDS 2026, Organised by TCEB, as International Design Gathering Invites Visitors to Discover New Perspectives Through Exhibitions, Dialogue, and Immersive Experiences
  41. HGC Appoints Dr Frédéric Schepens as Chief Executive Officer
  42. Malaysia Airlines Secures Major Accolades for Service and MICE Offering
  43. Hire A Maid Makes Domestic Helper Recruitment More Convenient for Singapore Families Through Digital-First Approach
  44. Ayam Brand™ Nurtures Healthier Futures with #AyamBersamaMu: Bekal Sihat Masa Depan
  45. Huawei Launches LUTERRA® S2, Redefining the Future of Residential Energy Systems with Three Ultimate Innovations
  46. The 27th China International Education Annual Conference held a cloud dialogue, where Yin Yuzhen and Saikaos discussed the exchange of folk ecological education
  47. International Street Work Conference 2026 Concludes Following Hong Kong Debut
  48. WellEra and Capella Bring Together the Science of Wellness and the Art of Hospitality at Thailand’s First Capella-Branded Residences
  49. HKSTP Achieves Fruitful Success at Inaugural Participation in Singapore Urban Mobility Week 2026
  50. NANO Nuclear to Hold Fourth Quarter Business Update Webcast on November 30, 2026

Times Magazine

What is a passkey — and should you use one instead of a password?

Websites increasingly invite users to create a passkey. The unfamiliar name describes a simpler wa...

A quality cut to bills for Beaufort butcher

Victorians are increasingly turning to Easy Electric SEC to better understand their home energy op...

Mentoring - Raising a child is more than providing for one

Food, shelter, safety and schooling are essential. But the guidance children receive about how to ...

Technology

What is a passkey — and should you …

Websites increasingly invite users to create a passkey. The unfamiliar name describes a simpler wa...

Local News

Brisbane Airport’s second runway ha…

Two parallel runways give Queensland’s main airport more capacity and greater flexibility. For tra...

Culture

Health is connected. Your data should be too.

Why health data matters most when it helps people make better decisions in everyday life. The healt...

Travel

Travel Trends 2027: Why Asia-Pacific Travelle…

Travellers from Australia and Southeast Asia are spending more on what they do and less on where t...

The Times Features

Choosing the Right Childcare for Your Family

Selecting the appropriate childcare for your family represents a significant decision, impacting bot...

Health is connected. Your data should be too.

Why health data matters most when it helps people make better decisions in everyday life. The healt...

Why Construction Heavyweights Are Backing This Brisbane…

Backed by Antler, McNab Group, Hutchinson Builders, KPAT and private investors, Casu is building a...